Armis Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Armis Advisers's LLY Position: Q3 2026 in Review
Armis Advisers increased its Eli Lilly (LLY) stake by 14% in Q3 2026, buying an estimated $566K and bringing the position to 4,010 shares worth $4.74M. The position accounts for 0.4% of the portfolio, ranked #40.
Armis Advisers first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 1,223 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Armis Advisers held 4,010 shares of Eli Lilly worth $4.74M as of Q3 2026.
- Armis Advisers bought 480 Eli Lilly shares in Q3 2026, an estimated $566K.
- Eli Lilly made up 0.4% of Armis Advisers's portfolio in Q3 2026, its #40 holding.
- Armis Advisers first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 1,223 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.